A recent study has shed light on the lack of mental health support for prostate cancer patients. Experts are urging for mental health screenings to be a standard part of the diagnostic process for prostate cancer following the concerning findings of the research conducted by the University of South Australia.
The study, which involved over 13,000 South Australian men with prostate cancer and was funded by Movember, revealed that 15% of patients started taking mental health medications immediately after their diagnosis, while only 6% sought help from mental health services. This highlights a significant gap between those who receive support and those who likely need it, with up to 40% of prostate cancer patients being at risk of mental distress.
Despite the high survival rate of prostate cancer, survivors often struggle with psychological issues post-treatment. Dr. Tenaw Tiruye, the lead researcher, estimated that one in six patients experience clinical depression following their diagnosis. He also emphasized the higher rates of depression, anxiety, and suicide risk among prostate cancer patients compared to the general population.
Dr. Kerri Beckmann, the senior researcher, emphasized the need for societal shifts to reduce the stigma around mental health challenges that prostate cancer patients face. She called for mental health care to be integrated into standard prostate cancer diagnosis routines to ensure prompt support for patients during their diagnosis period.
With over 24,000 people receiving a prostate cancer diagnosis each year, it is crucial to address the lack of mental health support for these patients. By implementing mental health screenings and providing adequate support, healthcare providers can help improve the overall well-being and quality of life for prostate cancer patients. It is essential to prioritize mental health alongside physical health in cancer care to ensure holistic support for patients throughout their journey.